| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/18/2004 | WO2004022102A2 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022087A1 Use of disease-associated gene |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022075A1 Treatment of neurological disorders by dsrna adminitration |
| 03/18/2004 | WO2004022006A2 Methods of diagnosing cervical cancer |
| 03/18/2004 | WO2004022003A2 Materials and methods for treatment of allergic diseases |
| 03/18/2004 | WO2004021986A2 Improved compositions and methods for cdna synthesis |
| 03/18/2004 | WO2004021978A2 Antisense modulation of endothelial specific molecule 1 expression |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021871A2 Hcv assay |
| 03/18/2004 | WO2004021772A2 Immune cloning and uses thereof |
| 03/18/2004 | WO2004015098A3 Rhesus epithelial cell adhesion molecule, nucleic acid encoding the same, and uses thereof |
| 03/18/2004 | WO2004011601A8 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 03/18/2004 | WO2004009841A3 Method of identifying genes involved in cell growth regulation |
| 03/18/2004 | WO2004009631A3 Human gnrh (type 2) receptor |
| 03/18/2004 | WO2004007712A3 Modulating developmental pathways in plants |
| 03/18/2004 | WO2004007697A3 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 03/18/2004 | WO2004003208A3 Stress tolerant plant |
| 03/18/2004 | WO2004003186A3 Subtilases and subtilase variants having altered immunogenicity |
| 03/18/2004 | WO2004001042A3 Microarrays displaying encoded molecules |
| 03/18/2004 | WO2003106653A3 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof |
| 03/18/2004 | WO2003105755A3 Antisense modulation of vegf-c expression |
| 03/18/2004 | WO2003102201A3 Methods and materials for the production of d-lactic acid in yeast |
| 03/18/2004 | WO2003102127A3 Human 5-ht7 receptor promoter sequence |
| 03/18/2004 | WO2003100557A3 Computer systems and methods for subdividing a complex disease into component diseases |
| 03/18/2004 | WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 03/18/2004 | WO2003097673A3 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
| 03/18/2004 | WO2003095628A3 Control of es cell self renewal and lineage specification, and medium therefor |
| 03/18/2004 | WO2003093794A3 Methods for discovering tumor biomarkers and diagnosing tumors |
| 03/18/2004 | WO2003093426A3 In vitro mutagenesis, phenotyping, and gene mapping |
| 03/18/2004 | WO2003093307A3 Mycobacterial antigens and uses thereof |
| 03/18/2004 | WO2003092714A3 Peptide variants of ige constrained by beta-lactam bond |
| 03/18/2004 | WO2003087149A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087148A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087146A3 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism |
| 03/18/2004 | WO2003087142A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003084471A8 Compositions selective for adenosine diphosphate and methods of using same |
| 03/18/2004 | WO2003080825A3 Further bmp-2 inducible kinases and the uses thereof |
| 03/18/2004 | WO2003078645A3 Methods for generating double stranded dna comprising a 3’ single stranded portion and uses of these complexes for recombination |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003075944A3 Interferon beta-like molecules for treatment of stroke |
| 03/18/2004 | WO2003072822A3 Mononucleotide repeats microsatellite markers for detecting microsatellite instability. |
| 03/18/2004 | WO2003072792A3 A method of selectively producing male or female sterile plants |
| 03/18/2004 | WO2003072603A3 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003069979A3 Plant preparations |
| 03/18/2004 | WO2003068961A3 Method to modify differentiation of pluripotential stem cells |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003064623A3 Methods and vectors for facilitating site-specific recombination |
| 03/18/2004 | WO2003054509A3 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003053340A3 Antisense modulation of connective tissue growth factor expression |
| 03/18/2004 | WO2003050531A3 Method for displaying loops from immunoglobulin domains in different contexts |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003040314A3 E1-revertant-free adenoviral composition |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003038039A3 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003032809A3 Modulation of akt-dependent response to prevent restenosis |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003025195A3 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof |
| 03/18/2004 | WO2003022202A3 Compositions and methods for treatment of cancer |
| 03/18/2004 | WO2003013228A3 Biochemistry-related polynucleotides and polypeptides in plants |
| 03/18/2004 | WO2003012028A3 Line retrotransposable elements with rnase h enzyme activity and use of same |
| 03/18/2004 | WO2003011014A3 Novel constitutive and tissue specific plant promoters and their utilization |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2003006641A3 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 03/18/2004 | WO2003004599A3 Methods of making and using expression constructs for the expression of recombinant proteins |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002103011A3 Selective gene amplification |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002102970A3 Flax (linum usitatissimim l.) seed-specific promoters |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090570A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002076280A3 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 03/18/2004 | WO2002063009A3 Lp mammalian proteins; related reagents |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040055041 Method for genetic transformation of woody trees |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055039 Expression vector coding regulatory sequence for transcription of heterologous nucleotide sequences in fruit of plants; tissue engineering |
| 03/18/2004 | US20040055038 Methods and compositions for regulated transcription and expression of heterologous genes |
| 03/18/2004 | US20040055037 Plasmid comprising, internal ribosome entry sites and capable of amplification, expression and polycistronic cap independent translation; genetic engineering |
| 03/18/2004 | US20040055036 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 03/18/2004 | US20040055035 Hybrid maize plant & seed 38F10 |
| 03/18/2004 | US20040055032 Pyrophosphatase stress-related proteins and methods of use in plants |
| 03/18/2004 | US20040055030 Sperm cell processing and preservation systems |
| 03/18/2004 | US20040055028 Urocortin-deficient mice and uses thereof |
| 03/18/2004 | US20040055027 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 03/18/2004 | US20040055026 Neurological disease model |
| 03/18/2004 | US20040055025 Using nuclear transplantation to generate transgenic animal models for harvesting polyclonal antibodies |
| 03/18/2004 | US20040055024 Conditional mutants of influenza virus M2 protein |
| 03/18/2004 | US20040055023 Animal models which concurrently expresses insulin and glucokinase gene in muscle cells; treating pancreatic disorders |
| 03/18/2004 | US20040055022 Compositions and methods for screening therapeutic agents |
| 03/18/2004 | US20040054480 Three dimensional structures and models of Fc receptors and uses thereof |